Patent classifications
C
C12
C12N
2710/00
C12N2710/00011
C12N2710/16011
C12N2710/16061
C12N2710/16064
C12N2710/16064
Live attenuated infectious laryngotracheitis virus (ILTV) vaccines and preparation thereof
This disclosure describes a modified live infectious laryngotracheitis virus (ILTV) developed from a strain of ILTV grown at a reduced incubation temperature, vaccines that include the modified live ILTV, methods for producing the live modified ILTV, and methods that include administering the modified ILTV to a subject.